Neuromedin S (NMS), a peptide structurally related to NMU, has been identified in the mammalian heart tissues. However to date, any role of NMS in cardiomyocytes and the relevant mechanisms still remain unknown. In this study, we identified a novel functional role of NMS in modulating L-type Ca(2+) channels in adult rat ventricular myocytes, in which NMU type 2 receptors (NMUR2), but not NMUR1,...

There are several reports available on neuroleptic malignant syndrome (NMS) associated with risperidone but when a more stringent criterion is applied there are only a few. Report on challenge and rechallenge with various atypical antipsychotic drugs in re-emergence of post NMS psychosis is scanty. Our aim of presenting this is to highlight the differential response of various atypical antipsyc...

Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening side-effect that can occur in response to treatment with antipsychotic drugs. Symptoms commonly include hyperpyrexia, muscle rigidity, autonomic dysfunction and altered mental status. In the current review we provide an overview on past and current developments in understanding the causes and treatment of NMS. Studi...

Background Glioblastoma is one of the most aggressive and common malignancies of the central nervous system in humans. Owing to the correlation of high Hsp90 expression with prognosis and clinical pathology features of diverse types of cancer, targeting Hsp90 with small-molecule inhibitors has become a promising anticancer strategy. Purpose In this study, we aimed to explore the possibility o...

PURPOSE The nonmotor symptoms (NMS) of Parkinson's disease (PD) are important factors for quality of life (QoL). Few studies on NMS have been conducted in Asian PD patients. Additionally, effects of anti-PD drugs on risk of NMS are still controversial. We therefore conducted this hospital-based cross-sectional study to examine the clinical factors, including concomitant anti-PD medication use, ...

To the Editors: The neuroleptic malignant syndrome (NMS) is a rare but potentially fatal adverse event associated with the use of conventional and atypical antipsychotic medications. In addition to the commonly observed symptoms of fever, muscular rigidity, autonomic dysregulation, and delirium, several abnormalities in laboratory indices are also associated with NMS. Laboratory abnormalities c...

OBJECTIVE Nonmotor symptoms (NMS) are common in patients with established Parkinson disease (PD) but their frequency in early PD has not been extensively studied. Our aim was to determine the frequency of NMS in a cohort of patients with newly diagnosed PD. METHODS A total of 159 patients with early PD and 99 healthy controls participated in this study. NMS were screened for using the nonmoto...

BACKGROUND Quantitative susceptibility mapping (QSM) has been used to measure iron accumulation in the deep nuclei of patients with Parkinson's disease (PD). This study examined the relationship between non-motor symptoms (NMSs) and iron accumulation in the deep nuclei of patients with PD. METHODS The QSM data were acquired from 3-Tesla magnetic resonance imaging (MRI) in 29 patients with ear...

The liver has a crucial role in metabolic homeostasis, as it is responsible for the storage, synthesis, metabolism and redistribution of carbohydrates, fats and vitamins, and numerous essential proteins. It is also the principal detoxification centre of the body, removing xenobiotics and waste products by metabolism or biliary excretion. An increasing number of studies have shown that some nano...

Background & Objective: Non-Motor Symptoms (NMS) are common in Parkinson’s disease (PD). While prevalence of each NMS in Thai PD patients is unknown, these NMS might have an impact on patients’ wellbeing. The aim of this study is to identify the prevalence, pattern and impact of NMS on the quality of life in Thai PD patients. Methods: A cross-sectional study in 115 PD patients was conducted at ...